Hoselito Joseph Prodan - 05 Sep 2023 Form 4 Insider Report for Bird Global, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Sep 2023, 19:22:34 UTC
Prior SEC filing
06 Sep 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Courtney Schoch, Attorney-in-Fact

Key filing fact

Hoselito Joseph Prodan filed Form 4 for Bird Global, Inc. on 06 Sep 2023.

Key facts

  • This page summarizes Hoselito Joseph Prodan's Form 4 filing for Bird Global, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Sep 2023, 19:22.

Change

  • Previous filing in this sequence was filed on 06 Sep 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BRDS transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+75,000
Change %
+250%
Price
$0.000000
Shares after
105,000
Date
05 Sep 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs") under Issuer's 2021 Incentive Award Plan; each RSU will vest as to 1/12 of the total RSUs on December 1, 2023, and 1/12 of each of the first 11 quarterly anniversaries thereafter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .